Skip to main content

Qube Research & Technologies Ltd

Position in KROS — Keros Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in KROS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,514,555
-$1,488,628 QoQ
Shares Held
608,837
-16.0% QoQ
Ownership
3.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 132 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. KROS ranks #66 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,514,555 608,837
2026-03-31 $8,003,183 724,926
2025-12-31 $15,960,570 783,918
2025-09-30 $4,795,390 303,122
2025-06-30 $516,337 38,677
2025-03-31 $2,785,354 273,342
2024-09-30 $1,622,533 27,941
2024-06-30 $1,427,439 31,235
2024-03-31 $149,744 2,262
2023-12-31 $1,373,389 34,542
2023-09-30 $285,581 8,958
2023-06-30 $1,078,350 26,838
2023-03-31 $1,605,989 37,611
2022-12-31 $623,299 12,980
2022-09-30 $828,241 22,016
2022-06-30 $1,492,876 54,031